In a recent study, Chen et al. reported that DEX treatment may alleviate cognitive impairment in hypoxic–ischemic neonatal rats by activating hippocampal neurogenesis through the BDNF/TrkB/CREB signaling pathway [21]. The gene discussed is NTRK2; the disease is Cognitive impairment.